THE OPPORTUNITY

Health care is full of innovations that work, and stories that don't travel. Breakthrough digital therapeutics, AI-powered diagnostics, and precision oncology tools are changing what's possible for patients, but only when the people who fund, deploy, and prescribe them can see themselves in the story. These three pieces were each written at a consequential moment: a payer needing a new case for mental health intervention, a health system navigating an AI-first transformation, and a pharma sponsor confronting a systemic gap between testing and treatment. The opportunity in each was the same, make something complex, unfamiliar, and high-stakes feel inevitable. 

THE STORY

Ibex Medical Analytics — NHS Wales was drowning. Post-pandemic backlogs, understaffed labs, and a cancer care system under extreme pressure created an urgent need for a different kind of solution. The story wasn't just about technology, it was about one pathologist's vision, a government willing to bet on AI first, and what happens when a health system stops waiting and starts leading.

Freespira — For decades, patients with panic disorder and PTSD were told their symptoms were all in their head. The science said otherwise, and the real story was physiological, measurable, and fixable in 28 days without a single drug. The challenge was making a health plan or employer believe that a breathing device could outperform a prescription and pay for itself in year one.

OncoLens — Patients with cancer were being tested for biomarkers at rates well below clinical guidelines, and in many cases, even when a mutation was found, fewer than one in five received the targeted therapy indicated. The data was stark, the gaps were systemic, and the story had to move a Big 10 pharma sponsor and frontline oncologists to act. The work turned a quality improvement dataset into a call to action no care team could ignore.

Selected Writing Samples

A selection of long-form content developed for health technology clients, white papers, case studies, and market narratives translating complex clinical evidence for payer, provider, and life science audiences.

Freespira — A white paper written for health plan and employer audiences at the moment digital therapeutics were entering the behavioral health conversation. The piece had to do two things at once: establish the physiological science behind panic disorder and PTSD, and make the economic case for a 28-day drug-free intervention in a market conditioned to reach for a prescription.

Ibex Medical Analytics / NHS Wales — A case study written for a global health technology audience at the frontier of AI adoption in clinical settings. The piece chronicles the world's first country-wide deployment of AI-powered cancer diagnostics, from a health system under strain to a internationally referenceable model for pathology transformation.

OncoLens — A case study commissioned by a Big 10 pharma sponsor to surface real-world gaps in biomarker testing and targeted therapy adoption across cancer programs. Written for oncologists, multidisciplinary care teams, and life science decision-makers, the piece translates granular quality improvement data into a clinically credible, commercially actionable narrative.